SCHEMBL7717987

SCHEMBL7717987

CCCN(C(=O)c1c(NC)c2c(Cl)cccc2n(C)c1=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.41
▸ GPBAR1 Q8TDU6 1/20 0.39
▸ MEN1 O00255 10/20 0.38
▸ KMT2A Q03164 10/20 0.38
▸ PGR P06401 1/20 0.38
▸ TP53 P04637 2/20 0.38
▸ MAP3K5 Q99683 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ POLB P06746 3/20 0.35
▸ PABPC1 P11940 1/20 0.35
▸ CNR2 P34972 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ CRHBP P24387 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166395 0.92 TP53 (0.47) EGFRGPBAR1MEN1KMT2APGR
SCHEMBL7600507 0.87 MEN1 (0.47) EGFRGPBAR1MEN1KMT2APGR
SCHEMBL5167604 0.84 MEN1 (0.55) EGFRGPBAR1MEN1KMT2APGR
SCHEMBL7718082 0.79 MEN1 (0.45) EGFRMEN1KMT2APGRTP53
SCHEMBL19114836 0.79 TP53 (0.51) EGFRGPBAR1MEN1KMT2APGR
Laquinimod SCHEMBL39440 0.78 TP53 (0.50) EGFRGPBAR1MEN1KMT2APGR
Laquinimod SCHEMBL29438575 0.78 TP53 (0.50) EGFRGPBAR1MEN1KMT2APGR
Laquinimod SCHEMBL1573337 0.77 TP53 (0.49) EGFRGPBAR1MEN1KMT2APGR
SCHEMBL19628902 0.77 MEN1 (0.48) MEN1KMT2APGRTP53MAP3K5
SCHEMBL19114839 0.77 TP53 (0.49) EGFRGPBAR1MEN1KMT2APGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US disclosed
Send feedback